Insider Transactions in Q2 2024 at United Therapeutics Corp (UTHR)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 04
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
15,000
-44.71%
|
$3,480,000
$232.69 P/Share
|
|
Apr 04
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+49.78%
|
$1,935,000
$129.49 P/Share
|
|
Apr 04
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
6,000
-2.94%
|
$1,392,000
$232.02 P/Share
|
|
Apr 04
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+12.32%
|
$702,000
$117.76 P/Share
|
|
Apr 03
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
15,000
-48.6%
|
$3,435,000
$229.11 P/Share
|
|
Apr 03
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+49.78%
|
$1,935,000
$129.49 P/Share
|
|
Apr 02
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
15,000
-52.88%
|
$3,420,000
$229.0 P/Share
|
|
Apr 02
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+49.78%
|
$1,935,000
$129.49 P/Share
|
|
Apr 01
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
15,000
-30.52%
|
$3,390,000
$226.62 P/Share
|
|
Apr 01
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+49.78%
|
$1,935,000
$129.49 P/Share
|